ButlerRJ. Impact of nocturnal enuresis on children and young people. Scand J Urol Nephrol2001;35:169–76.
2.
FergussonDMHorwoodLJShannonFT. Factors related to the age of attainment of nocturnal bladder control: an 8-year longitudinal study. Pediatrics1986;78:884.
3.
BakkerEvan SprundelMvan der AuweraJCvan GoolJD. Voiding habits and wetting in a population of 4,332 Belgian school children aged between 10–14 years. Scand J Urol Nephrol2002;36:354.
4.
HoweACWalkerCE. Behavioral management of toilet training, enuresis, and encopresis. Pediatr Clin North Am1992;39:413.
5.
ForsytheWIRedmondA. Enuresis and spontaneous cure rate. Study of 1129 enuretics. Arch Dis Child1974;49:259–63.
6.
KlackenbergG. Nocturnal enuresis in a longitudinal perspective. A primary problem of maturity and/or a secondary environmental reaction?Acta Paediatr Scand1981;70:453.
StadtlerACGorskiPABrazeltonBT. Toilet training methods, clinical interventions, and recommendations. Pediatrics1999;103:1359.
9.
WolfishNM. Sleep/arousal and enuresis subtypes. J Urol2001;166 (6):2444–7.
10.
JalkutMWLermanSEChurchillBM. Enuresis. Pediatr Clin North Am2001;48:1461.
11.
Ullon-MinnichMR. Diagnosis and management of nocturnal enuresis. Am Fam Physician1996;54:2259.
12.
CendronM. Primary nocturnal enuresis: current. Am Fam Physician1999;59:1205.
13.
van GoolJDBloomDAButlerRJCommittee 12: conservative management in children. In: AbramsPKhourySWeinA, editors. Health Publication Ltd. First International Consultation on Incontinence; 1998 Jun 28–Jul 1; Monaco. p. 487–550.
14.
Canadian Pediatric SocietyManagement of primary nocturnal enuresis. Paediatr Child Health2005;10 (10):611–4. Available: www.cps.ca/English/statements/CP/cp05-02.htm (accessed August 26, 2008).
15.
HjalmasKArnoldTBowerWNocturnal enuresis: an international evidence-based management strategy. J Urol2004;171 (6 Pt 2):2545–61.
16.
AladjemMWohlRBoichisHDesmopressin in nocturnal enuresis. Arch Dis Child1982;57 (2):137–40.
17.
Del GadoRDel GaizoDCennamoMDesmopressin is a safe drug for the treatment of enuresis. Scand J Urol Nephrol2005;39:308–12.
18.
DDAVP tablets [product monograph]. Toronto (ON): Ferring Pharmaceuticals; 2006.
19.
LawlessMRMcElderryDH. Nocturnal enuresis: current concepts. Pediatr Rev2001;22 (12):399–407.
20.
NatochinYVKuznetsovaAA. Defect of osmoregulatory renal function in nocturnal enuresis. Scand J Urol Nephrol Suppl1999;33 (202):40–4.
21.
SkoogSJStokesATurnerKL. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis. J Urol1997;158 (3 Pt 2):1035–40.
22.
HjalmasKBengtssonB. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe. Clin Pediatr1993;Spec No:19–24.
23.
EllerDAAustinPFTanguaySHomsyYL. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis. Eur Urol1998;33Suppl 3:25–9.
Vande WalleJGBogaertGAMattssonSA new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int2006;97:603–9.
28.
LottmanHFroelingFAlloussiSA randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis. Int J Clin Pract2007;1–7.
29.
European Medicines Agency (EMEA)Reflection paper: formulations of choice for the paediatric population. London (UK): EMEA; 2006. p. 9, 22.
30.
MacLeanR. Imipramine hydrochloride (Tofranil) and enuresis. Am J Psychiatry1960;117:551.
31.
US Food and Drug AdministrationFDA news: FDA proposes new warnings about suicidal thinking, behavior in young adults who take antidepressant medications. 2007 May 2. Available: www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html (accessed August 26, 2008).
32.
FritzGKRockneyRMYeungAS. Plasma levels and efficacy of imipramine treatment for enuresis. J Am Acad Child Adolesc Psychiatry1994;33:60.
33.
Persson-JunemannCSeemannOKohrmannKUComparison of urodynamic findings and response to oxybutynin in nocturnal enuresis. Eur Urol1993;24:92.
34.
LoveringJSTallettSEMcKendryJB. Oxybutynin efficacy in the treatment of primary enuresis. Pediatrics1988;82 (1):104–6.
35.
GlazenerCMEvansJHPetoRE. Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev2003;(3):CD002117.